73.82

0.52% 0.38

Pre-market: 71.39 -2.43 -3.29%

Sol Gel Technologies Ltd (SLGL)

Overview News Price History Option Chain Discussions Forecast

Sol Gel Technologies Ltd stock is traded at $73.82, with a volume of 33,850. It is up +0.52% in the last 24 hours and up +1.51% over the past month. Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

Previous Close:

$73.44

Open:

$73

24h Volume:

33,850

Relative Volume:

0.80

Market Cap:

$241.32M

Revenue:

$18.47M

Net Income/Loss:

$-1.05M

P/E Ratio:

-210.13

EPS:

-0.3513

Net Cash Flow:

$-33.87M

1W Performance:

-7.73%

1M Performance:

+1.51%

6M Performance:

+72.60%

1Y Performance:

+881.65%

1-Day Range:

$71.63

$74.33

1-Week Range:

$70.45

$80.99

52-Week Range:

$6.91

$97.97

Sol Gel Technologies Ltd Stock (SLGL) Company Profile

Name

Sol Gel Technologies Ltd

Sector

Healthcare (1104)

Industry

Biotechnology (621)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-05-29

Latest SEC Filings

SLGL's Discussions on Twitter

Compare SLGL vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SLGL Sol Gel Technologies Ltd	73.82	241.32M	18.47M	-1.05M	-33.87M	-0.3513
VRTX Vertex Pharmaceuticals Inc	450.46	114.33B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	614.98	64.47B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	884.20	54.99B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	287.80	38.42B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	160.06	34.03B	742.00K	-1.37B	-1.07B	-7.0731

Sol Gel Technologies Ltd Stock (SLGL) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-19-24	Downgrade	Raymond James	Strong Buy → Outperform
Oct-21-22	Resumed	Jefferies	Hold
Dec-31-19	Reiterated	H.C. Wainwright	Buy
Dec-31-19	Reiterated	JMP Securities	Mkt Outperform

Sol Gel Technologies Ltd Stock (SLGL) Latest News

Jun 09, 2026

Phoenix Financial Ltd. (SLGL) reports 4.99% ownership of Sol‑Gel shares - Stock Titan

Jun 09, 2026

Jun 08, 2026

Sol-Gel Technologies Ltd. Q1 2026 Earnings: EPS Beat Drives Modest Stock Uptick Despite Continued Pre-Revenue StatusGuidance Update - newsline.com

Jun 08, 2026

Jun 05, 2026

SLGL Q1 2026 Earnings: Smaller-Than-Expected Loss Drives Stock HigherNext Quarter Guidance - newsline.com

Jun 05, 2026

May 29, 2026

TD Cowen initiates Sol Gel stock with buy on dermatology drug - Investing.com Nigeria

May 29, 2026

LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $184 - Moomoo

May 29, 2026

TD Cowen Initiates Sol-Gel Technologies at Buy - Moomoo

May 29, 2026

Sol-Gel Technologies (SLGL) Reports First Quarter Revenue Decline - GuruFocus

May 29, 2026

May 28, 2026

Sol Gel Technologies Q1 Loss On US$0.1 Million Revenue Fuels Bearish Narrative - simplywall.st

May 28, 2026

Sol Gel Tech earnings beat by $3.15, revenue fell short of estimates - Investing.com Australia

May 28, 2026